SMHD1_HUMAN - dbPTM
SMHD1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SMHD1_HUMAN
UniProt AC A6NHR9
Protein Name Structural maintenance of chromosomes flexible hinge domain-containing protein 1
Gene Name SMCHD1
Organism Homo sapiens (Human).
Sequence Length 2005
Subcellular Localization Chromosome .
Protein Description Required for maintenance of X inactivation in females and hypermethylation of CpG islands associated with inactive X. Involved in a pathway that mediates the methylation of a subset of CpG islands slowly and requires the methyltransferase DNMT3B (By similarity). Required for DUX4 silencing in somatic cells. [PubMed: 23143600]
Protein Sequence MAAADGGGPGGASVGTEEDGGGVGHRTVYLFDRREKESELGDRPLQVGERSDYAGFRACVCQTLGISPEEKFVITTTSRKEITCDNFDETVKDGVTLYLLQSVNQLLLTATKERIDFLPHYDTLVKSGMYEYYASEGQNPLPFALAELIDNSLSATSRNIGVRRIQIKLLFDETQGKPAVAVIDNGRGMTSKQLNNWAVYRLSKFTRQGDFESDHSGYVRPVPVPRSLNSDISYFGVGGKQAVFFVGQSARMISKPADSQDVHELVLSKEDFEKKEKNKEAIYSGYIRNRKPSDSVHITNDDERFLHHLIIEEKEKDSFTAVVITGVQPEHIQYLKNYFHLWTRQLAHIYHYYIHGPKGNEIRTSKEVEPFNNIDIEISMFEKGKVPKIVNLREIQDDMQTLYVNTAADSFEFKAHVEGDGVVEGIIRYHPFLYDRETYPDDPCFPSKLKDEDDEDDCFILEKAARGKRPIFECFWNGRLIPYTSVEDFDWCTPPKKRGLAPIECYNRISGALFTNDKFQVSTNKLTFMDLELKLKDKNTLFTRILNGQEQRMKIDREFALWLKDCHEKYDKQIKFTLFKGVITRPDLPSKKQGPWATYAAIEWDGKIYKAGQLVKTIKTLPLFYGSIVRFFLYGDHDGEVYATGGEVQIAMEPQALYDEVRTVPIAKLDRTVAEKAVKKYVEDEMARLPDRLSVTWPEGDELLPNEVRPAGTPIGALRIEILNKKGEAMQKLPGTSHGGSKKLLVELKVILHSSSGNKEIISHISQHGGKWPYWFKKMENIQKLGNYTLKLQVVLNESNADTYAGRPLPSKAIKFSVKEGKPEKFSFGLLDLPFRVGVPFNIPLEFQDEFGHTSQLVTDIQPVLEASGLSLHYEEITKGPNCVIRGVTAKGPVNSCQGKNYNLKVTLPGLKEDSQILKIRLLPGHPRRLKVKPDSEILVIENGTAFPFQVEVLDESDNITAQPKLIVHCKFSGAPNLPVYVVDCSSSGTSILTGSAIQVQNIKKDQTLKARIEIPSCKDVAPVEKTIKLLPSSHVARLQIFSVEGQKAIQIKHQDEVNWIAGDIMHNLIFQMYDEGEREINITSALAEKIKVNWTPEINKEHLLQGLLPDVQVPTSVKDMRYCQVSFQDDHVSLESAFTVRPLPDEPKHLKCEMKGGKTVQMGQELQGEVVIIITDQYGNQIQAFSPSSLSSLSIAGVGLDSSNLKTTFQENTQSISVRGIKFIPGPPGNKDLCFTWREFSDFIRVQLISGPPAKLLLIDWPELKESIPVINGRDLQNPIIVQLCDQWDNPAPVQHVKISLTKASNLKLMPSNQQHKTDEKGRANLGVFSVFAPRGEHTLQVKAIYNKSIIEGPIIKLMILPDPEKPVRLNVKYDKDASFLAGGLFTDFMISVISEDDSIIKNINPARISMKMWKLSTSGNRPPANAETFSCNKIKDNDKEDGCFYFRDKVIPNKVGTYCIQFGFMMDKTNILNSEQVIVEVLPNQPVKLVPKIKPPTPAVSNVRSVASRTLVRDLHLSITDDYDNHTGIDLVGTIIATIKGSNEEDTDTPLFIGKVRTLEFPFVNGSAEIMSLVLAESSPGRDSTEYFIVFEPRLPLLSRTLEPYILPFMFYNDVKKQQQMAALTKEKDQLSQSIVMYKSLFEASQQLLNEMKCQVEEARLKEAQLRNELKIHNIDIPTTQQVPHIEALLKRKLSEQEELKKKPRRSCTLPNYTKGSGDVLGKIAHLAQIEDDRAAMVISWHLASDMDCVVTLTTDAARRIYDETQGRQQVLPLDSIYKKTLPDWKRSLPHFRNGKLYFKPIGDPVFARDLLTFPDNVEHCETVFGMLLGDTIILDNLDAANHYRKEVVKITHCPTLLTRDGDRIRSNGKFGGLQNKAPPMDKLRGMVFGAPVPKQCLILGEQIDLLQQYRSAVCKLDSVNKDLNSQLEYLRTPDMRKKKQELDEHEKNLKLIEEKLGMTPIRKCNDSLRHSPKVETTDCPVPPKRMRREATRQNRIITKTDV
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MAAADGGGP
------CCCCCCCCC
23.7419413330
13PhosphorylationGGGPGGASVGTEEDG
CCCCCCCCCCCCCCC
25.1025849741
16PhosphorylationPGGASVGTEEDGGGV
CCCCCCCCCCCCCCC
33.7625850435
26MethylationDGGGVGHRTVYLFDR
CCCCCCCEEEEEEEC
21.69115383241
36AcetylationYLFDRREKESELGDR
EEEECCCCCCCCCCC
65.8025953088
36UbiquitinationYLFDRREKESELGDR
EEEECCCCCCCCCCC
65.8029967540
64UbiquitinationRACVCQTLGISPEEK
CHHHHHHCCCCHHHC
2.0621890473
67PhosphorylationVCQTLGISPEEKFVI
HHHHCCCCHHHCEEE
25.1828450419
75PhosphorylationPEEKFVITTTSRKEI
HHHCEEEEECCCCEE
20.7920068231
76PhosphorylationEEKFVITTTSRKEIT
HHCEEEEECCCCEEE
16.2020068231
77PhosphorylationEKFVITTTSRKEITC
HCEEEEECCCCEEEC
20.2020068231
78PhosphorylationKFVITTTSRKEITCD
CEEEEECCCCEEECC
38.9820068231
80AcetylationVITTTSRKEITCDNF
EEEECCCCEEECCCC
53.9227452117
80UbiquitinationVITTTSRKEITCDNF
EEEECCCCEEECCCC
53.9229967540
121PhosphorylationRIDFLPHYDTLVKSG
HHHCCCCHHHHHHHC
14.5327642862
123PhosphorylationDFLPHYDTLVKSGMY
HCCCCHHHHHHHCCC
26.7023186163
177AcetylationLFDETQGKPAVAVID
EEECCCCCCEEEEEE
21.7126051181
177UbiquitinationLFDETQGKPAVAVID
EEECCCCCCEEEEEE
21.7129967540
191 (in isoform 3)Ubiquitination-14.9821890473
192UbiquitinationNGRGMTSKQLNNWAV
CCCCCCHHHHHHHHH
50.0323000965
192 (in isoform 1)Ubiquitination-50.0321890473
192 (in isoform 2)Ubiquitination-50.0321890473
213PhosphorylationTRQGDFESDHSGYVR
CCCCCCCCCCCCCCC
40.3926714015
240UbiquitinationSYFGVGGKQAVFFVG
CEECCCCCEEEEEEE
29.20-
254PhosphorylationGQSARMISKPADSQD
ECCCEEECCCCCCCC
24.2023312004
259PhosphorylationMISKPADSQDVHELV
EECCCCCCCCHHHHH
30.3227067055
269UbiquitinationVHELVLSKEDFEKKE
HHHHHHCHHHHHHHH
58.0829967540
283PhosphorylationEKNKEAIYSGYIRNR
HHCHHHHHHHCCCCC
11.7723917254
291UbiquitinationSGYIRNRKPSDSVHI
HHCCCCCCCCCCEEE
53.04-
293PhosphorylationYIRNRKPSDSVHITN
CCCCCCCCCCEEECC
45.6229255136
295PhosphorylationRNRKPSDSVHITNDD
CCCCCCCCEEECCCC
21.6720873877
299PhosphorylationPSDSVHITNDDERFL
CCCCEEECCCCHHHH
20.0923312004
309 (in isoform 3)Ubiquitination-2.6921890473
314UbiquitinationHHLIIEEKEKDSFTA
HHHHEEECCCCCCEE
58.2229967540
388UbiquitinationFEKGKVPKIVNLREI
ECCCCCCEEECHHHH
63.3729967540
392UbiquitinationKVPKIVNLREIQDDM
CCCEEECHHHHCCHH
3.4421890473
431UbiquitinationEGIIRYHPFLYDRET
EEEEEECCCCCCCCC
16.4121890473
448AcetylationDDPCFPSKLKDEDDE
CCCCCCCCCCCCCCC
60.8526051181
448UbiquitinationDDPCFPSKLKDEDDE
CCCCCCCCCCCCCCC
60.8529967540
450AcetylationPCFPSKLKDEDDEDD
CCCCCCCCCCCCCCC
63.9126822725
450UbiquitinationPCFPSKLKDEDDEDD
CCCCCCCCCCCCCCC
63.9129967540
452UbiquitinationFPSKLKDEDDEDDCF
CCCCCCCCCCCCCCC
66.8221890473
463AcetylationDDCFILEKAARGKRP
CCCCHHHHHHCCCCC
43.8526822725
463UbiquitinationDDCFILEKAARGKRP
CCCCHHHHHHCCCCC
43.8529967540
491UbiquitinationTSVEDFDWCTPPKKR
CCHHCCCCCCCCCCC
6.4621890473
492 (in isoform 3)Ubiquitination-4.3921890473
493PhosphorylationVEDFDWCTPPKKRGL
HHCCCCCCCCCCCCC
38.0728348404
496UbiquitinationFDWCTPPKKRGLAPI
CCCCCCCCCCCCCCH
57.20-
497UbiquitinationDWCTPPKKRGLAPIE
CCCCCCCCCCCCCHH
58.43-
525UbiquitinationKFQVSTNKLTFMDLE
CEEEECCCEEEEEEE
49.3329967540
538UbiquitinationLELKLKDKNTLFTRI
EEEEECCCCHHHHHH
50.6929967540
564UbiquitinationREFALWLKDCHEKYD
HHHHHHHHHHHHHHH
46.8829967540
580AcetylationQIKFTLFKGVITRPD
CCEEEEEECEECCCC
56.2126051181
580UbiquitinationQIKFTLFKGVITRPD
CCEEEEEECEECCCC
56.2121890473
580 (in isoform 1)Ubiquitination-56.2121890473
580 (in isoform 2)Ubiquitination-56.2121890473
590PhosphorylationITRPDLPSKKQGPWA
ECCCCCCCCCCCCCE
60.8424719451
590UbiquitinationITRPDLPSKKQGPWA
ECCCCCCCCCCCCCE
60.8423000965
591AcetylationTRPDLPSKKQGPWAT
CCCCCCCCCCCCCEE
47.3725953088
591UbiquitinationTRPDLPSKKQGPWAT
CCCCCCCCCCCCCEE
47.3729967540
596UbiquitinationPSKKQGPWATYAAIE
CCCCCCCCEEEEEEE
14.2021890473
599PhosphorylationKQGPWATYAAIEWDG
CCCCCEEEEEEEECC
6.0617924679
609PhosphorylationIEWDGKIYKAGQLVK
EEECCEEEEHHHHHH
9.7717924679
610UbiquitinationEWDGKIYKAGQLVKT
EECCEEEEHHHHHHH
49.9029967540
616AcetylationYKAGQLVKTIKTLPL
EEHHHHHHHHHHHHC
53.8026051181
616UbiquitinationYKAGQLVKTIKTLPL
EEHHHHHHHHHHHHC
53.8029967540
619AcetylationGQLVKTIKTLPLFYG
HHHHHHHHHHHCCCC
49.6025953088
619UbiquitinationGQLVKTIKTLPLFYG
HHHHHHHHHHHCCCC
49.6021890473
619 (in isoform 1)Ubiquitination-49.6021890473
619 (in isoform 2)Ubiquitination-49.6021890473
620PhosphorylationQLVKTIKTLPLFYGS
HHHHHHHHHHCCCCC
29.7421406692
624UbiquitinationTIKTLPLFYGSIVRF
HHHHHHCCCCCEEEE
6.4821963094
625PhosphorylationIKTLPLFYGSIVRFF
HHHHHCCCCCEEEEE
20.0421406692
627PhosphorylationTLPLFYGSIVRFFLY
HHHCCCCCEEEEEEE
13.4121406692
627UbiquitinationTLPLFYGSIVRFFLY
HHHCCCCCEEEEEEE
13.4122817900
650UbiquitinationATGGEVQIAMEPQAL
EECCEEEEEECCHHH
4.8123000965
656UbiquitinationQIAMEPQALYDEVRT
EEEECCHHHHCCCCC
20.8521890473
668AcetylationVRTVPIAKLDRTVAE
CCCCCHHHHCHHHHH
52.2023749302
668UbiquitinationVRTVPIAKLDRTVAE
CCCCCHHHHCHHHHH
52.20-
672PhosphorylationPIAKLDRTVAEKAVK
CHHHHCHHHHHHHHH
24.5920068231
676AcetylationLDRTVAEKAVKKYVE
HCHHHHHHHHHHHHH
49.0625953088
684UbiquitinationAVKKYVEDEMARLPD
HHHHHHHHHHHCCCC
40.7121963094
687UbiquitinationKYVEDEMARLPDRLS
HHHHHHHHCCCCCCE
14.0722817900
725UbiquitinationLRIEILNKKGEAMQK
HEEEEECCCCHHHHH
59.7229967540
732UbiquitinationKKGEAMQKLPGTSHG
CCCHHHHHCCCCCCC
43.4929967540
737 (in isoform 3)Ubiquitination-26.5021890473
754PhosphorylationELKVILHSSSGNKEI
EEEEEEECCCCCHHH
23.8230266825
755PhosphorylationLKVILHSSSGNKEII
EEEEEECCCCCHHHH
31.3630266825
756PhosphorylationKVILHSSSGNKEIIS
EEEEECCCCCHHHHH
49.7730266825
759UbiquitinationLHSSSGNKEIISHIS
EECCCCCHHHHHHHH
54.5429967540
771AcetylationHISQHGGKWPYWFKK
HHHHCCCCCCCHHHH
49.9823954790
777AcetylationGKWPYWFKKMENIQK
CCCCCHHHHCHHHHH
36.7426051181
778UbiquitinationKWPYWFKKMENIQKL
CCCCHHHHCHHHHHH
41.8123000965
784AcetylationKKMENIQKLGNYTLK
HHCHHHHHHCCEEEE
55.3426051181
784UbiquitinationKKMENIQKLGNYTLK
HHCHHHHHHCCEEEE
55.3423000965
784 (in isoform 1)Ubiquitination-55.3421890473
784 (in isoform 2)Ubiquitination-55.3421890473
811PhosphorylationYAGRPLPSKAIKFSV
CCCCCCCCCCEEEEE
42.2624719451
812AcetylationAGRPLPSKAIKFSVK
CCCCCCCCCEEEEEE
52.7926051181
812UbiquitinationAGRPLPSKAIKFSVK
CCCCCCCCCEEEEEE
52.7921963094
812 (in isoform 1)Ubiquitination-52.7921890473
812 (in isoform 2)Ubiquitination-52.7921890473
815AcetylationPLPSKAIKFSVKEGK
CCCCCCEEEEEECCC
36.1225953088
815UbiquitinationPLPSKAIKFSVKEGK
CCCCCCEEEEEECCC
36.1222817900
819UbiquitinationKAIKFSVKEGKPEKF
CCEEEEEECCCCCCE
60.6029967540
822UbiquitinationKFSVKEGKPEKFSFG
EEEEECCCCCCEEEE
51.61-
860UbiquitinationHTSQLVTDIQPVLEA
CHHHEEEHHHHHHHH
30.0021890473
865UbiquitinationVTDIQPVLEASGLSL
EEHHHHHHHHCCCEE
6.0723000965
891AcetylationVIRGVTAKGPVNSCQ
EEEECEECCCCCCCC
55.1525953088
891UbiquitinationVIRGVTAKGPVNSCQ
EEEECEECCCCCCCC
55.1529967540
900AcetylationPVNSCQGKNYNLKVT
CCCCCCCCCCEEEEE
30.3126051181
900UbiquitinationPVNSCQGKNYNLKVT
CCCCCCCCCCEEEEE
30.3129967540
902UbiquitinationNSCQGKNYNLKVTLP
CCCCCCCCEEEEECC
25.9223503661
904UbiquitinationCQGKNYNLKVTLPGL
CCCCCCEEEEECCCC
3.1323503661
905AcetylationQGKNYNLKVTLPGLK
CCCCCEEEEECCCCC
29.5430592515
912UbiquitinationKVTLPGLKEDSQILK
EEECCCCCCCCCEEE
66.45-
919AcetylationKEDSQILKIRLLPGH
CCCCCEEEEEECCCC
27.6625953088
920UbiquitinationEDSQILKIRLLPGHP
CCCCEEEEEECCCCC
3.1721890473
925UbiquitinationLKIRLLPGHPRRLKV
EEEEECCCCCCCCCC
43.3223000965
962UbiquitinationDESDNITAQPKLIVH
CCCCCCCCCCEEEEE
21.6323503661
964UbiquitinationSDNITAQPKLIVHCK
CCCCCCCCEEEEEEE
30.8423503661
1019AcetylationRIEIPSCKDVAPVEK
EEECCCCCCCCCHHH
60.6226051181
1019UbiquitinationRIEIPSCKDVAPVEK
EEECCCCCCCCCHHH
60.6232015554
1026AcetylationKDVAPVEKTIKLLPS
CCCCCHHHHEEECCC
56.6426051181
1026UbiquitinationKDVAPVEKTIKLLPS
CCCCCHHHHEEECCC
56.6429967540
1033PhosphorylationKTIKLLPSSHVARLQ
HHEEECCCCCEEEEE
32.8023312004
1034PhosphorylationTIKLLPSSHVARLQI
HEEECCCCCEEEEEE
21.7523312004
1048UbiquitinationIFSVEGQKAIQIKHQ
EEEECCCEEEEEEEH
59.3123000965
1048 (in isoform 1)Ubiquitination-59.3121890473
1048 (in isoform 2)Ubiquitination-59.3121890473
1053UbiquitinationGQKAIQIKHQDEVNW
CCEEEEEEEHHHCCH
20.8823000965
1068UbiquitinationIAGDIMHNLIFQMYD
HHHHHHHHHHHHCCC
19.9021890473
1078UbiquitinationFQMYDEGEREINITS
HHCCCCCCCEEECCH
45.1323503661
1090UbiquitinationITSALAEKIKVNWTP
CCHHHHHHHCCCCCC
42.0723503661
1090 (in isoform 2)Ubiquitination-42.07-
1092UbiquitinationSALAEKIKVNWTPEI
HHHHHHHCCCCCCCC
40.3523503661
1101UbiquitinationNWTPEINKEHLLQGL
CCCCCCCHHHHHHCC
52.7729967540
1119UbiquitinationVQVPTSVKDMRYCQV
CCCCCCCCCCCEEEE
45.6432015554
1128UbiquitinationMRYCQVSFQDDHVSL
CCEEEEEECCCCEEE
10.9621890473
1138UbiquitinationDHVSLESAFTVRPLP
CCEEEEECEEEEECC
8.5123503661
1186UbiquitinationYGNQIQAFSPSSLSS
CCCEEEEECHHHCCC
6.7221890473
1189UbiquitinationQIQAFSPSSLSSLSI
EEEEECHHHCCCCEE
42.5923000965
1208PhosphorylationLDSSNLKTTFQENTQ
CCCCCCCCCCHHCCC
35.69-
1209PhosphorylationDSSNLKTTFQENTQS
CCCCCCCCCHHCCCC
23.02-
1232AcetylationIPGPPGNKDLCFTWR
ECCCCCCCCCEEEHH
58.9726051181
1246UbiquitinationREFSDFIRVQLISGP
HHCCCCEEEEECCCC
15.3221890473
1249UbiquitinationSDFIRVQLISGPPAK
CCCEEEEECCCCCCE
2.8523000965
1256UbiquitinationLISGPPAKLLLIDWP
ECCCCCCEEEEEECH
45.5021890473
1256 (in isoform 1)Ubiquitination-45.5021890473
1256 (in isoform 2)Ubiquitination-45.5021890473
1266UbiquitinationLIDWPELKESIPVIN
EEECHHHHHHCCEEC
47.9933845483
1266 (in isoform 2)Ubiquitination-47.99-
1301PhosphorylationPVQHVKISLTKASNL
CCCEEEEEEEEHHCC
25.0324719451
1304MalonylationHVKISLTKASNLKLM
EEEEEEEEHHCCEEC
55.9326320211
1304UbiquitinationHVKISLTKASNLKLM
EEEEEEEEHHCCEEC
55.9329967540
1349AcetylationQVKAIYNKSIIEGPI
EEEEEEECCCEECCE
26.5119608861
1349UbiquitinationQVKAIYNKSIIEGPI
EEEEEEECCCEECCE
26.5132015554
1358AcetylationIIEGPIIKLMILPDP
CEECCEEEEEECCCC
32.4918585689
1367AcetylationMILPDPEKPVRLNVK
EECCCCCCCEEEEEE
54.9518585699
1367NeddylationMILPDPEKPVRLNVK
EECCCCCCCEEEEEE
54.9532015554
1369UbiquitinationLPDPEKPVRLNVKYD
CCCCCCCEEEEEECC
18.8423503661
1374SumoylationKPVRLNVKYDKDASF
CCEEEEEECCCCCHH
46.81-
1374NeddylationKPVRLNVKYDKDASF
CCEEEEEECCCCCHH
46.8132015554
1374SumoylationKPVRLNVKYDKDASF
CCEEEEEECCCCCHH
46.8128112733
1374UbiquitinationKPVRLNVKYDKDASF
CCEEEEEECCCCCHH
46.8123000965
1374 (in isoform 1)Ubiquitination-46.8121890473
1374 (in isoform 2)Ubiquitination-46.8121890473
1377UbiquitinationRLNVKYDKDASFLAG
EEEEECCCCCHHHCC
52.7023000965
1400PhosphorylationSVISEDDSIIKNINP
EEECCCCCHHHCCCH
38.2424719451
1420PhosphorylationKMWKLSTSGNRPPAN
EEEEECCCCCCCCCC
30.6028985074
1429UbiquitinationNRPPANAETFSCNKI
CCCCCCCCEEEECCC
50.6323503661
1430UbiquitinationRPPANAETFSCNKIK
CCCCCCCEEEECCCC
20.5923503661
1431UbiquitinationPPANAETFSCNKIKD
CCCCCCEEEECCCCC
6.2023503661
1435UbiquitinationAETFSCNKIKDNDKE
CCEEEECCCCCCCCC
56.3032015554
1437AcetylationTFSCNKIKDNDKEDG
EEEECCCCCCCCCCC
52.6825953088
1437UbiquitinationTFSCNKIKDNDKEDG
EEEECCCCCCCCCCC
52.6829967540
1441UbiquitinationNKIKDNDKEDGCFYF
CCCCCCCCCCCCEEE
65.0529967540
1451UbiquitinationGCFYFRDKVIPNKVG
CCEEECCCCCCCCCE
37.5029967540
1490UbiquitinationVLPNQPVKLVPKIKP
ECCCCCCEECCCCCC
50.9123503661
1491UbiquitinationLPNQPVKLVPKIKPP
CCCCCCEECCCCCCC
8.9723503661
1496SumoylationVKLVPKIKPPTPAVS
CEECCCCCCCCCCCC
51.5828112733
1499PhosphorylationVPKIKPPTPAVSNVR
CCCCCCCCCCCCCHH
32.1920068231
1503PhosphorylationKPPTPAVSNVRSVAS
CCCCCCCCCHHHHHH
31.5420068231
1507PhosphorylationPAVSNVRSVASRTLV
CCCCCHHHHHHHHHH
20.1124719451
1544PhosphorylationIIATIKGSNEEDTDT
EEEEEECCCCCCCCC
35.7520860994
1557UbiquitinationDTPLFIGKVRTLEFP
CCCEEEEEEEEEECC
24.5921906983
1557 (in isoform 1)Ubiquitination-24.5921890473
1557 (in isoform 2)Ubiquitination-24.5921890473
1614UbiquitinationYILPFMFYNDVKKQQ
CCHHHHCCHHHHHHH
9.9221890473
1618UbiquitinationFMFYNDVKKQQQMAA
HHCCHHHHHHHHHHH
47.9623503661
1618 (in isoform 2)Ubiquitination-47.96-
1619UbiquitinationMFYNDVKKQQQMAAL
HCCHHHHHHHHHHHH
53.8623503661
1627PhosphorylationQQQMAALTKEKDQLS
HHHHHHHHHHHHHHH
32.2229743597
1628UbiquitinationQQMAALTKEKDQLSQ
HHHHHHHHHHHHHHH
64.7132015554
1636PhosphorylationEKDQLSQSIVMYKSL
HHHHHHHHHHHHHHH
17.4928555341
1642PhosphorylationQSIVMYKSLFEASQQ
HHHHHHHHHHHHHHH
22.3228555341
1647PhosphorylationYKSLFEASQQLLNEM
HHHHHHHHHHHHHHH
15.9728555341
1655UbiquitinationQQLLNEMKCQVEEAR
HHHHHHHHHHHHHHH
18.4832015554
1664UbiquitinationQVEEARLKEAQLRNE
HHHHHHHHHHHHHHC
45.5129967540
1674UbiquitinationQLRNELKIHNIDIPT
HHHHCCEECCCCCCC
4.7421890473
1693AcetylationPHIEALLKRKLSEQE
CCHHHHHHHHCCHHH
48.6225953088
1697PhosphorylationALLKRKLSEQEELKK
HHHHHHCCHHHHHHC
40.0229255136
1703AcetylationLSEQEELKKKPRRSC
CCHHHHHHCCCCCCC
63.1323749302
1703UbiquitinationLSEQEELKKKPRRSC
CCHHHHHHCCCCCCC
63.1332015554
1709PhosphorylationLKKKPRRSCTLPNYT
HHCCCCCCCCCCCCC
16.8425159151
1711PhosphorylationKKPRRSCTLPNYTKG
CCCCCCCCCCCCCCC
46.6330108239
1715PhosphorylationRSCTLPNYTKGSGDV
CCCCCCCCCCCCCCH
14.1128985074
1716PhosphorylationSCTLPNYTKGSGDVL
CCCCCCCCCCCCCHH
35.2529396449
1717AcetylationCTLPNYTKGSGDVLG
CCCCCCCCCCCCHHH
40.4926051181
1725UbiquitinationGSGDVLGKIAHLAQI
CCCCHHHHHHHHHHC
32.34-
1762UbiquitinationLTTDAARRIYDETQG
EEHHHHHHHHHHCCC
27.3921890473
1767PhosphorylationARRIYDETQGRQQVL
HHHHHHHCCCCCCEE
33.1630576142
1770UbiquitinationIYDETQGRQQVLPLD
HHHHCCCCCCEECHH
17.5921890473
1778PhosphorylationQQVLPLDSIYKKTLP
CCEECHHHHHCCCCC
35.1930576142
1780PhosphorylationVLPLDSIYKKTLPDW
EECHHHHHCCCCCHH
15.4721406692
1781AcetylationLPLDSIYKKTLPDWK
ECHHHHHCCCCCHHH
37.3025953088
1782UbiquitinationPLDSIYKKTLPDWKR
CHHHHHCCCCCHHHH
38.0229967540
1788UbiquitinationKKTLPDWKRSLPHFR
CCCCCHHHHHCCCCC
39.2229967540
1790PhosphorylationTLPDWKRSLPHFRNG
CCCHHHHHCCCCCCC
42.3929214152
1798AcetylationLPHFRNGKLYFKPIG
CCCCCCCEEEEEECC
43.4925953088
1802AcetylationRNGKLYFKPIGDPVF
CCCEEEEEECCCCEE
23.3625953088
1802SuccinylationRNGKLYFKPIGDPVF
CCCEEEEEECCCCEE
23.36-
1802SuccinylationRNGKLYFKPIGDPVF
CCCEEEEEECCCCEE
23.3621890473
1802UbiquitinationRNGKLYFKPIGDPVF
CCCEEEEEECCCCEE
23.3621890473
1802 (in isoform 1)Ubiquitination-23.3621890473
1802 (in isoform 2)Ubiquitination-23.3621890473
1822UbiquitinationTFPDNVEHCETVFGM
CCCCCHHHHHHHHHH
15.4921890473
1830UbiquitinationCETVFGMLLGDTIIL
HHHHHHHHHCCEEEE
5.0421890473
1872AcetylationDRIRSNGKFGGLQNK
CCCCCCCCCCCCCCC
45.1223749302
1885AcetylationNKAPPMDKLRGMVFG
CCCCCHHHHCCHHCC
33.5626051181
19182-HydroxyisobutyrylationQYRSAVCKLDSVNKD
HHHHHHHHHHHCCCH
49.05-
1918UbiquitinationQYRSAVCKLDSVNKD
HHHHHHHHHHHCCCH
49.0529967540
1921PhosphorylationSAVCKLDSVNKDLNS
HHHHHHHHCCCHHHH
37.72-
1924UbiquitinationCKLDSVNKDLNSQLE
HHHHHCCCHHHHHHH
62.5329967540
1928PhosphorylationSVNKDLNSQLEYLRT
HCCCHHHHHHHHHCC
43.3628348404
1932PhosphorylationDLNSQLEYLRTPDMR
HHHHHHHHHCCHHHH
15.2928555341
1935PhosphorylationSQLEYLRTPDMRKKK
HHHHHHCCHHHHHHH
22.5028348404
1950UbiquitinationQELDEHEKNLKLIEE
HHHHHHHHHHHHHHH
70.2821890473
1950 (in isoform 1)Ubiquitination-70.2821890473
1958UbiquitinationNLKLIEEKLGMTPIR
HHHHHHHHHCCCCCH
37.2332015554
1958 (in isoform 1)Ubiquitination-37.2321890473
1962PhosphorylationIEEKLGMTPIRKCND
HHHHHCCCCCHHCCH
17.4821815630
1970PhosphorylationPIRKCNDSLRHSPKV
CCHHCCHHHCCCCCC
17.2024732914
1974PhosphorylationCNDSLRHSPKVETTD
CCHHHCCCCCCCCCC
21.7123143600
1979PhosphorylationRHSPKVETTDCPVPP
CCCCCCCCCCCCCCC
30.8123403867
1980PhosphorylationHSPKVETTDCPVPPK
CCCCCCCCCCCCCCH
23.3024732914
2001PhosphorylationTRQNRIITKTDV---
HHHCCCEECCCC---
26.0630266825
2002SumoylationRQNRIITKTDV----
HHCCCEECCCC----
32.11-
2002SumoylationRQNRIITKTDV----
HHCCCEECCCC----
32.11-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of SMHD1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SMHD1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SMHD1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ECM29_HUMANKIAA0368physical
26344197
MB12A_HUMANMVB12Aphysical
26344197
TRI25_HUMANTRIM25physical
26344197
SYWC_HUMANWARSphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
158901Facioscapulohumeral muscular dystrophy 2 (FSHD2)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SMHD1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1349, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-599 AND TYR-609, ANDMASS SPECTROMETRY.

TOP